Fuda Cancer Hospital
Fuda Cancer Hospital
Chiny, Kanton
Terapia hormonalna w Chinach kosztuje zazwyczaj od $3,500 do $9,800. Końcowa cena zależy od stanu zdrowia, formy leku i wybranej placówki. Pacjenci oszczędzają około 0% w porównaniu z cenami w Polsce, gdzie leczenie to kosztuje średnio $2,500. Cena zazwyczaj obejmuje konsultacje wstępne oraz diagnostyczne badania hormonów w wyspecjalizowanych ośrodkach.
Opinia ekspercka Bookimed: Wybór specjalistycznych ośrodków onkologicznych, takich jak Fuda Cancer Hospital, przynosi wymierne korzyści. Ta posiadająca akredytację JCI placówka w Kantonie przyjmuje ponad 30 000 pacjentów zagranicznych. Skupia się na mało inwazyjnych terapiach zamiast tradycyjnej chemioterapii. W przypadku nowotworów hormonozależnych podejście to łączy zaawansowaną diagnostykę z indywidualnymi protokołami endokrynologicznymi. Strategia ta często daje lepsze efekty u pacjentów w późnym stadium niż standardowa farmakoterapia.
| Chiny | Turcja | Austria | |
| Hormonterapia | od $3,500 | od $400 | od $7,000 |
| Terapia deprywacyjna androgenowa | od $3,800 | od $1,500 | od $4,500 |
Państwo nie płacą za usługi Bookimed. Ceny na hormonterapię na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu hormonterapii. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Hormonterapia.
Dzień 1 - Przyjazd
Dzień 2 - Konsultacja przedoperacyjna
Dzień 3 - Wyniki badań i plan leczenia
Dzień 4 - Rozpoczęcie terapii hormonalnej
Dzień 5-14 - Kontynuacja terapii
Tydzień 3 - Monitorowanie pooperacyjne
Tydzień 4 - Rehabilitacja
Tydzień 6
Tydzień 8
Zwróć uwagę, że jest to ogólny przewodnik, a indywidualne doświadczenia mogą się różnić. Zawsze konsultuj się ze swoim lekarzem prowadzącym w celu uzyskania indywidualnych porad.
Menopausal hormone therapy in China is historically uncommon, with uptake rates among postmenopausal women typically ranging from 2% to 3%. While usage is currently surging in major urban centers, traditional cultural perspectives and safety concerns regarding oncological risks often limit broader clinical adoption.
Bookimed Expert Insight: While overall national rates remain low, international-standard facilities like JCI-accredited Fuda Cancer Hospital demonstrate how Chinese medical infrastructure integrates advanced hormonal monitoring. Patients seeking this therapy should target Tier-1 cities like Guangzhou or Shanghai. Research indicates that private clinics and oncology centers often provide more specialized endocrine screening than smaller regional hospitals.
Patient Consensus: Many women report being told to simply endure symptoms as a natural life stage. Patients often must advocate strongly for themselves or seek international-friendly clinics to access modern Western formulations.
Gender-affirming hormone therapy is legally available in China but subject to strict centralized regulation. Patients must obtain a formal gender dysphoria diagnosis from a licensed psychiatrist before accessing treatment. Prescriptions are primarily managed through specialized clinics in major metropolitan hubs like Shanghai, Beijing, and Guangzhou.
Bookimed Expert Insight: Legality in China is highly dependent on individual hospital policy rather than a single national mandate. While facilities like the Childrens Hospital of Fudan University pave the way, clinicians often interpret rules differently. If one provider refuses care, seeking a second opinion at a Joint Commission International-accredited facility in a different city is a common and effective strategy.
Patient Consensus: The process often feels like proving legitimacy through exhausting paperwork rather than informed consent. Many patients emphasize that navigating the formal hospital system is emotionally draining but critical for ensuring medication quality and proper bloodwork monitoring.
Transgender individuals cannot legally purchase hormone replacement therapy medications online in China. National regulations enacted in December 2022 strictly prohibit the e-commerce sale of estradiol, cyproterone acetate, and testosterone. Valid hospital prescriptions do not override this absolute ban for online retail platforms.
Bookimed Expert Insight: While hospital-based therapy costs $3,500 to $9,800, the real barrier is geographical. Specialized clinics are concentrated in Beijing and Shanghai, leaving patients in other provinces without stable, regulated medication access.
Patient Consensus: Many individuals face dangerous supply interruptions through unregulated sellers. Patients emphasize that maintaining a consistent dose is nearly impossible without a local hospital connection.
Menopause treatment in China integrates Western hormonal therapy with Traditional Chinese Medicine to manage vasomotor symptoms and insomnia. Common prescriptions include estradiol-based compounds like Femoston, tibolone for women aged 51–60, and herbal proprietary medicines such as Kun-tai capsules or Liu Wei Di Huang Wan.
Bookimed Expert Insight: Chinese clinical practice significantly favors a conservative, integrated approach compared to Western protocols. Data suggests that combining Traditional Chinese Medicine with lower-dose Western hormones reduces adverse reactions while effectively managing symptoms. Patients often receive specific herbal formulas like Xiao Yao San alongside standard estradiol to address the psychological aspects of menopause.
Patient Consensus: Patients value how clinicians address specific complaints like sleep and bone protection rather than a one-size-fits-all pill. Many appreciate the availability of micronized progesterone for its sleep benefits despite occasional reports of vivid dreams.
Chinese women frequently integrate Traditional Chinese Medicine (TCM) with conventional hormone therapy, a practice known as integrated traditional Chinese and Western medicine. This combined approach manages symptoms like hot flashes and mood swings while reducing pharmaceutical side effects for menopause, infertility, and cancer recovery care.
Bookimed Expert Insight: While traditional methods are popular, specialized centers like Fuda Cancer Hospital in Guangzhou demonstrate the value of JCI-accredited oversight. Combining ancient herbal wisdom with advanced technologies like NanoKnife ensures that integrated treatments stay evidence-based. Patients should prioritize clinics that offer standardized, reputable traditional care instead of using unlabeled products for safety.
Patient Consensus: Patients emphasize that traditional treatments provide extra relief but warn about the importance of reporting all herbs to doctors. Most appreciate acupuncture for its perceived safety profile compared to the unpredictability of some herbal products.